Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist and HCG vs Progesterone for Luteal Phase Support in Natural Cycle FET
NCT05838105Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Oct 2022
- Primary completion
- Jan 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of triptorelin and recombinant human chorionic gonadotrophin in infertility (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Clinical pregnancy rate. Status: unknown.
02
Drugs
triptorelinrecombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05838105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838105.